Covered recipient · General Payments record
LISA Y HARRIS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018
$5,709.81
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,150.00 | 2 |
| Travel and Lodging | $1,187.18 | 4 |
| Food and Beverage | $372.63 | 10 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $5,622.16 | 9 |
| Lilly USA, LLC | $28.01 | 2 |
| Novo Nordisk AS | $26.08 | 2 |
| Acerta Pharma LLC | $21.60 | 2 |
| Supernus Pharmaceuticals, Inc. | $11.96 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $5,709.81 | 16 |
Payment records · PY2018 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $125.00 | 03/01/2018 | Food and Beverage | Undisputed | 01/23/2026 | 569080720 | CMS |
| Amgen Inc. | $141.46 | 03/01/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 569080735 | CMS |
| Amgen Inc. | $479.86 | 03/01/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 569080745 | CMS |
| Amgen Inc. | $443.60 | 03/01/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 569080751 | CMS |
| Amgen Inc. | $150.00 | 03/02/2018 | Food and Beverage | Undisputed | 01/23/2026 | 569080724 | CMS |
| Amgen Inc. | $122.26 | 03/03/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 569080741 | CMS |
| Amgen Inc. | $1,350.00 | 04/02/2018 | Consulting Fee | Undisputed | 01/23/2026 | 569080711 | CMS |
| Amgen Inc. | $2,800.00 | 04/02/2018 | Consulting Fee | Undisputed | 01/23/2026 | 569080717 | CMS |
| Amgen Inc. | $9.98 | 06/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | 567591519 | CMS |
| AstraZeneca Pharmaceuticals LP | $10.63 | 03/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | 560308439 | CMS |
| AstraZeneca Pharmaceuticals LP | $10.97 | 07/10/2018 | Food and Beverage | Undisputed | 01/23/2026 | 559695013 | CMS |
| Lilly USA, LLC | $15.71 | 06/29/2018 | Food and Beverage | Undisputed | 01/23/2026 | 559489803 | CMS |
| Lilly USA, LLC | $12.30 | 07/16/2018 | Food and Beverage | Undisputed | 01/23/2026 | 559489809 | CMS |
| Novo Nordisk Inc | $14.42 | 04/25/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587893917 | CMS |
| Novo Nordisk Inc | $11.66 | 07/25/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587893919 | CMS |
| Supernus Pharmaceuticals, Inc. | $11.96 | 06/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | 615723335 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.